Big Pharma Split Corp.

Historical Distributions

(For the purposes of the Income Tax Act (Canada) and any corresponding provincial or territorial legislation, all dividends paid by Big Pharma Split Corp. on its Class A Shares and Preferred Shares are “eligible dividends”, unless otherwise indicated.)

2021

Record DatePRM
Distributions
PRM.PR.A
Distributions
2021-04-300.1031
2021-03-310.10310.1250
2021-02-260.1031
2021-02-190.7160
2021-01-290.1031

2020

Record DatePRM
Distributions
PRM.PR.A
Distributions
2020-12-310.10310.1250
2020-11-300.1031
2020-10-300.1031
2020-09-300.10310.1250
2020-08-310.1031
2020-07-310.1031
2020-06-300.10310.1250
2020-05-290.1031
2020-04-300.1031
2020-03-310.10310.1250
2020-02-280.1031
2020-01-310.1031

2019

Record DatePRM
Distributions
PRM.PR.A
Distributions
2019-12-310.10310.1250
2019-11-290.1031
2019-10-310.1031
2019-09-300.10310.1250
2019-08-300.1031
2019-07-310.1031
2019-06-280.10310.1250
2019-05-310.1031
2019-04-300.1031
2019-03-290.10310.1250
2019-02-280.1031
2019-01-310.1031

2018

Record DatePRM
Distributions
PRM.PR.A
Distributions
2018-12-310.10310.1250
2018-11-300.1031
2018-10-310.1031
2018-09-280.10310.1250
2018-08-310.1031
2018-07-310.1031
2018-06-290.10310.1250
2018-05-310.1031
2018-04-300.1031
2018-03-290.10310.1250
2018-02-280.1031
2018-01-310.1031

2017

Record DatePRM
Distributions
PRM.PR.A
Distributions
2017-12-290.10310.0516

April 30, 2021

Security %
Sanofi S.A. 10.5
AstraZeneca PLC 10.3
Pfizer Inc. 10.2
Amgen Inc. 9.8
AbbVie Inc. 9.8
Johnson & Johnson 9.7
Bristol-Myers Squibb Company 9.5
Merck & Co., Inc. 9.4
Novartis AG 9.3
Eli Lilly and Company 9.2
Foreign currency forwards 2.2
Cash and other assets and liabilities 0.5
Market value of equity options (0.3)

2021

Date Symbol NAV $ Distribution Total $

(Since Inception)

2021-05-07PRM14.385.046
2021-05-07PRM.PR.A10.001.677

Why Invest In This Fund?


Big Pharma Split Corp. will invest in an initially equally-weighted portfolio comprised of Equity Securities of ten issuers, selected by the Portfolio Manager from the Investable Universe, that at the time of investment and immediately following each semi-annual reconstitution and rebalancing: (i) are listed on a North American exchange; (ii) pay a dividend; and (iii) have options in respect of its Equity Securities that, in the opinion of the Portfolio Manager, are sufficiently liquid to permit the Portfolio Manager to write options in respect of such securities. The Portfolio will be comprised primarily of the largest (as determined by market capitalization calculated in US$) Pharmaceutical Issuers in the Investable Universe.

The Manager will hedge substantially all of the Portfolio’s U.S dollar exposure back to the Canadian dollar.

The Class A Shares provide holders a monthly cash distribution and are targeted to be $0.1031 per share and, for the Preferred Shares, quarterly cash distributions are fixed at $0.1250 per share.

Fund Quick Facts

April 30, 2021


TSX Code PRM  | PRM.PR.A
Cusip PRM 08934P108
Cusip PRM.PR.A 08934P207
Total AUM $31.2 million
Management Fee 0.75%
Number of Equity Securities 10
Income Distribution PRM Monthly
Income Distribution PRM.PR.A Quarterly
Distribution PRM $0.1031
Distribution PRM.PR.A $0.1250
Current Yield – PRM 9.00%
Distribution Method Cash
RSP Eligible RRSP/RRIF/RESP/TFSA

 

Portfolio Analysis*


Average Market Capitalization (CAD) 241B
Average Dividend Yield 3.37%
Average P/E 14.4x

Investor Documents

Quarterly Summary  Eng


Prospectus Eng | Fr

Portfolio Management

 

 

PAUL MACDONALD, CFAChief Investment Officer

JAMES LEARMONTH, CFASenior Portfolio Manager
MIKE
DRAGOSITS
, CFA
Portfolio Manager

Performance & Price

Historical Prices

Top Ten Portfolio Holdings


Security % of Total Assets
Sanofi S.A. 10.5
AstraZeneca PLC 10.3
Pfizer Inc. 10.2
Amgen Inc. 9.8
AbbVie Inc. 9.8
Johnson & Johnson 9.7
Bristol-Myers Squibb Company 9.5
Merck & Co., Inc. 9.4
Novartis AG 9.3
Eli Lilly and Company 9.2

Portfolio Allocation


Performance (%)

As at April 30, 2021

Symbol1M3M6MYTD1Y2Y3YSI
PRM1.062.4829.024.8911.7114.7813.2411.03
PRM.PR.A0.001.252.521.255.095.095.094.97

Download CSV

Symbol2020201920182017
PRM0.2420.2111.811.36
PRM.PR.A5.095.095.090.52

Download CSV

Cumulative Growth $10,000 Invested

 (NAV pricing)


Disclaimer

You will usually pay brokerage fees to your dealer if you purchase or sell units of the Fund on the TSX. If units are purchased or sold on the TSX, investors may pay more than the current net asset value when buying units of the Fund and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning units of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash from the Class A or Preferred Class of the Fund. If the Fund earns less than the amount distributed, the difference is a return of capital. The current yield is calculated based on the market price of the Fund.

The information contained herein is not an offer to sell nor a solicitation to buy any security. Such an offer can only be made by prospectus or other applicable offering document.

**Filed on SEDAR April 01, 2020 per NI 81-503 Extension of Certain Filing, Delivery and Prospectus Renewal Requirements of Investment Funds.

† The first year of Calendar Year Performance presents the rate of return from commencement of operations to December 31 of that year.

 

Subscribe to Our Newsletter and Stay Informed

Subscribe Now

Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *


Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *